Log In

Forgot Password?

OR

Not a member? Continue as a nonmember.

Become a Member

By becoming a member of the AAN, you can receive exclusive information to help you at every stage of your career. Benefits include:

Join Now See All Benefits

Loading... please wait

2022 Annual Meeting | S8 - General Neurology: Clinical Treatment and Practice

Sunday 04/03/22
03:30 PM - 05:30 PM PDT Add To Calendar
This program will be presented both in-person and online
This program will be available in the meeting's On Demand product.
Scientific Platform Session
General Neurology
2.00 CME credits

Program Materials Program Evaluations

Event Timeline
03:30 PM - 03:30 PM PDT Speaker walk in slides
Erin Jackson
03:30 PM - 03:42 PM PDT Abstract 001 - Clinical Diversity of Patients with Neuronal Intranuclear Inclusion Disease
Tomoko Okamoto
03:42 PM - 03:54 PM PDT Abstract 002 - Cipaglucosidase alfa/miglustat Versus alglucosidase alfa/placebo in Late-onset Pompe Disease (LOPD): PROPEL Study Subgroup Analyses
Tahseen Mozaffar, MD, FAAN
03:54 PM - 04:06 PM PDT Abstract 003 - HELIOS-A: Results from the Phase 3 Study of Vutrisiran in Patients with Hereditary Transthyretin-Mediated Amyloidosis with Polyneuropathy
Michael J. Polydefkis, MD, FAAN
04:06 PM - 04:18 PM PDT Abstract 004 - Virtual vs In-person Neurological Exam Study (VINES) in Response to the COVID-19 Crisis and Beyond
Lauren Hophing, MD
04:18 PM - 04:30 PM PDT Abstract 005 - VA National TeleNeurology Program: Patient Characteristics and Access to Care
Steven S. Schreiber, MD
04:30 PM - 04:42 PM PDT Abstract 006 - Differential Associations of Kidney Function with Cerebral Gray and White Matter Tissue Health in Middle-Aged and Older Adults
Mei-jun Shu
04:42 PM - 04:54 PM PDT Abstract 007 - Longitudinal Evaluation of Neuro-PASC Symptoms
Andrew Valenciano, MD
05:06 PM - 05:18 PM PDT Abstract 009 - A Placebo-Controlled Phase I Study of NVG-291 in Healthy Subjects, Targeting CNS Receptor Protein Tyrosine Phosphatase Sigma (PTPs)
Daniel D. Mikol, MD, PhD
05:18 PM - 05:30 PM PDT Abstract 010 - Neutralizing Antibody Conversion With Onabotulinumtoxina From Global Studies Across Multiple Indications In Nearly 30,000 Patient Records: A Meta-Analysis
Mitchell F. Brin, MD, FAAN
Faculty Disclosures
Mitchell F. Brin, MD, FAAN Dr. Brin has received personal compensation for serving as an employee of Allergan. Dr. Brin has stock in Allergan.
Joseph Jankovic, MD, FAAN Dr. Jankovic has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Revance. Dr. Jankovic has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Revance, Allergan. The institution of Dr. Jankovic has received research support from Baylor College of Medicine. Dr. Jankovic has received research support from Abbvie. The institution of Dr. Jankovic has received research support from Abbvie.
Steven S. Schreiber, MD Dr. Schreiber has nothing to disclose.
Tahseen Mozaffar, MD, FAAN Dr. Mozaffar has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alexion Pharmaceuticals. Dr. Mozaffar has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Argenx. Dr. Mozaffar has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi-Genzyme. Dr. Mozaffar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amicus. Dr. Mozaffar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Modis Therapeutics. Dr. Mozaffar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB/ Ra Pharmaceuticals. Dr. Mozaffar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Maze Therapeutics. Dr. Mozaffar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Spark Therapeutics. Dr. Mozaffar has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. Dr. Mozaffar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for National Institutes of Health. Dr. Mozaffar has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Argenx. Dr. Mozaffar has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for Neuromuscular Disease Foundation. The institution of Dr. Mozaffar has received research support from NIH. The institution of Dr. Mozaffar has received research support from Muscular Dystrophy Association. The institution of Dr. Mozaffar has received research support from Sanofi-Genzyme. The institution of Dr. Mozaffar has received research support from Argenx. The institution of Dr. Mozaffar has received research support from Amicus Therapeutics. The institution of Dr. Mozaffar has received research support from Spark Therapeutics. The institution of Dr. Mozaffar has received research support from Audentes Therapeutics. The institution of Dr. Mozaffar has received research support from Cartesian. Dr. Mozaffar has received personal compensation in the range of $500-$4,999 for serving as a Study Section Member with NIH.
Linda S. Williams, MD, FAAN The institution of Dr. Williams has received research support from VA HSR&D.
Markus Naumann, MD No disclosure on file
Daniel D. Mikol, MD, PhD Dr. Mikol has received personal compensation for serving as an employee of NervGen. Dr. Mikol has received personal compensation for serving as an employee of Amgen. Dr. Mikol has received personal compensation in the range of $100,000-$499,999 for serving as an officer or member of the Board of Directors for NervGen. Dr. Mikol has stock in NervGen. Dr. Mikol has stock in Amgen. Dr. Mikol has received personal compensation in the range of $100,000-$499,999 for serving as a Employee with NervGen.
Violaine Plante-Bordeneuve, MD Dr. Plante-Bordeneuve has nothing to disclose.
Michael J. Polydefkis, MD, FAAN Dr. Polydefkis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alnylam Pharmaceuticals. Dr. Polydefkis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Akcea. Dr. Polydefkis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vertex Pharmaceutical . Dr. Polydefkis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen-Idec. Dr. Polydefkis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer.
Antonio Toscano, MD Dr. Toscano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi Genzyme.
David D. Adams David D. Adams has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for ALNYLAM. David D. Adams has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer.
Jayne R. Wilkinson, MD, MSCE Dr. Wilkinson has nothing to disclose.
Erin Jackson Ms. Jackson has nothing to disclose.
Toshiyuki Yamamoto Dr. Yamamoto has nothing to disclose.
Christopher B. Ransom, MD, PhD The institution of Dr. Ransom has received research support from Dept of Veterans Affairs, BLR&D.
Priya Kishnani, MD Priya Kishnani, MD has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi/Genzyme. Priya Kishnani, MD has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amicus Therapeutics. Priya Kishnani, MD has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Maze Therapeutics. Priya Kishnani, MD has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for JCR Pharmaceutical. Priya Kishnani, MD has received personal compensation in the range of $500,000-$999,999 for serving as a Consultant for Asklepios Biopharmaceutical Inc. (AskBio). Priya Kishnani, MD has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi/Genzyme. Priya Kishnani, MD has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Amicus Therapeutics. Priya Kishnani, MD has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Baebies, Inc.. The institution of Priya Kishnani, MD has received research support from Sanofi/Genzyme. Priya Kishnani, MD has received research support from Amicus Therapeutics. Priya Kishnani, MD has received intellectual property interests from a discovery or technology relating to health care. Priya Kishnani, MD has received intellectual property interests from a discovery or technology relating to health care.
Maria Alejandra Gonzalez Duarte, MD, FAAN Dr. Gonzalez Duarte has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alnylam. Dr. Gonzalez Duarte has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astra Zeneca. Dr. Gonzalez Duarte has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Anylam . The institution of Dr. Gonzalez Duarte has received research support from Pfizer.
Ivajlo Tournev No disclosure on file
Chongshu Chen Chongshu Chen has received personal compensation for serving as an employee of Alnylam Pharmaceuticals. Chongshu Chen has stock in Alnylam Pharmaceuticals.
Ans Van Der Ploeg The institution of Ans Van Der Ploeg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi Genzyme . The institution of Ans Van Der Ploeg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amicus. The institution of Ans Van Der Ploeg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Spark Therapeutics . The institution of Ans Van Der Ploeg has received research support from Sanofi Genzyme.
Jennifer Graves, MD, PhD Dr. Graves has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Graves has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Graves has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MSJ. The institution of Dr. Graves has received research support from Octave. The institution of Dr. Graves has received research support from Sanofi. The institution of Dr. Graves has received research support from EMD Serono.
John L. Berk John L. Berk has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alnylam Pharmaceuticals. John L. Berk has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ionis Pharmaceuticals. John L. Berk has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astra Zeneca/IONIS. John L. Berk has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eidos/BridgBio. John L. Berk has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Intellia Therapeutics. John L. Berk has received research support from Alnylam . John L. Berk has received research support from Ionis. John L. Berk has received research support from Eidos/Bridgbio.
Sara Berman Mitchell, MD Dr. Mitchell has nothing to disclose.
Barry Byrne Barry Byrne has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for AavantiBio. Barry Byrne has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer. Barry Byrne has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Vertex. Barry Byrne has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. Barry Byrne has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Muscular Dystrophy Association. Barry Byrne has received intellectual property interests from a discovery or technology relating to health care.
Teresa Coelho, MD Dr. Coelho has nothing to disclose.
Aditi Narechania, MD Dr. Narechania has nothing to disclose.
Charles Kassardjian, MD Dr. Kassardjian has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi Genzyme. Dr. Kassardjian has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Kassardjian has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Kassardjian has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Kassardjian has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Argenx.
Yi-Cheng Zhu, MD, PhD Dr. Zhu has nothing to disclose.
Rita Singh, PharmD Dr. Singh has received personal compensation for serving as an employee of AbbVie. Dr. Singh has stock in AbbVie.
Yoshiki Sekijima, "MD, PhD" Yoshiki Sekijima, "MD, PhD" has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alnylam. Yoshiki Sekijima, "MD, PhD" has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Pfizer.
Maxwell T. Ma, MD Dr. Ma has nothing to disclose.
Yuko Saito Yuko Saito has nothing to disclose.
Naomichi Matsumoto Naomichi Matsumoto has nothing to disclose.
Benedikt Schoser Benedikt Schoser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi Genzyme. Benedikt Schoser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amicus. Benedikt Schoser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer. Benedikt Schoser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Taysha. Benedikt Schoser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. Benedikt Schoser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Benedikt Schoser has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Taysha. Benedikt Schoser has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Kedrion.
Yuji Takahashi, MD, PhD The institution of Dr. Takahashi has received research support from Nihon Medi-Physics Co. Limit.. The institution of Dr. Takahashi has received research support from Takeda Pharmaceutical Company Limited.
Drago Bratkovic Drago Bratkovic has nothing to disclose.
Pascal Lafort Pascal Lafort has received personal compensation in the range of $500-$4,999 for serving as a Consultant for sanofi . An immediate family member of Pascal Lafort has received personal compensation in the range of $500-$4,999 for serving as a Consultant for biogen. Pascal Lafort has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Pascal Lafort has received personal compensation in the range of $0-$499 for serving as a Consultant for Amicus. Pascal Lafort has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Pascal Lafort has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for genzyme sanofi. Pascal Lafort has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sparks therapeutics. Pascal Lafort has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Pascal Lafort has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amicus therapeutics. Pascal Lafort has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ROCHE. Pascal Lafort has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Genzyme Sanofi. Pascal Lafort has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Revue Neurologique. The institution of Pascal Lafort has received research support from Genzyme Sanofi. The institution of Pascal Lafort has received research support from Genzyme sanofi. The institution of Pascal Lafort has received research support from Amicus therapeutics. The institution of Pascal Lafort has received research support from AMICUS Therapeutics.
Mark Roberts Mark Roberts has nothing to disclose.
Dilraj Singh Sokhi, FRCP Dr. Sokhi has nothing to disclose.
Li-Xin *USE ID 239100 Zhou Li-Xin Zhou has nothing to disclose.
Torge Rempe, MD Dr. Rempe has nothing to disclose.
Yuji Saitoh, MD Dr. Saitoh has received stock or an ownership interest from Meiji Holdings Co. Ltd.. Dr. Saitoh has received stock or an ownership interest from Daiichi Sankyo Co. Ltd.. Dr. Saitoh has received stock or an ownership interest from Japan Tobacco Inc.. Dr. Saitoh has received stock or an ownership interest from Otsuka Holdings Co., Ltd.. Dr. Saitoh has received stock or an ownership interest from Fujifilm Holdings Corporation. Dr. Saitoh has received stock or an ownership interest from Johnson & Johnson. Dr. Saitoh has received stock or an ownership interest from 3M Company. The institution of Dr. Saitoh has received research support from Japan Agency for Medical Research and Development (AMED). Dr. Saitoh has received publishing royalties from a publication relating to health care. Dr. Saitoh has received publishing royalties from a publication relating to health care. Dr. Saitoh has received publishing royalties from a publication relating to health care.
Masayuki Miyazaki Masayuki Miyazaki has nothing to disclose.
Tomoko Okamoto Tomoko Okamoto has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Novartis. The institution of Tomoko Okamoto has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Takeda Pharma. Tomoko Okamoto has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Biogen. The institution of Tomoko Okamoto has received research support from EA Pharma Co., Ltd. The institution of Tomoko Okamoto has received research support from Sanofi. The institution of Tomoko Okamoto has received research support from Novartis. Tomoko Okamoto has received intellectual property interests from a discovery or technology relating to health care.
Irina Yushmanova Irina Yushmanova has received personal compensation for serving as an employee of AbbVie.
Fei Han No disclosure on file
Zheng-Yu Jin No disclosure on file
Jun Ni Jun Ni has nothing to disclose.
Ming Yao No disclosure on file
Shu-Yang Zhang The institution of Shu-Yang Zhang has received research support from Chinese Academy of Medical Science.
Mei-jun Shu Mei-jun Shu has nothing to disclose.
Lauren Hophing, MD Dr. Hophing has nothing to disclose.
Noriko Sato Noriko Sato has nothing to disclose.
Ding-Ding Zhang Ding-Ding Zhang has nothing to disclose.
Jordi Diaz Manera No disclosure on file
John Vest John Vest has received personal compensation for serving as an employee of Alnylam Pharmaceuticals. John Vest has received stock or an ownership interest from Alnylam Pharmaceuticals. John Vest has received intellectual property interests from a discovery or technology relating to health care.
Houman Khosravani, MD, PhD Dr. Khosravani has nothing to disclose.
Li-Ying Cui No disclosure on file
Tadashi Tsukamoto Tadashi Tsukamoto has nothing to disclose.
Jasmit Shah Jasmit Shah has nothing to disclose.
Seth Arum Seth Arum has received personal compensation for serving as an employee of Alnylam Pharmaceuticals. Seth Arum has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wolters Kluwer.
Julian D. Gillmore Julian D. Gillmore has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alnylam Pharmaceuticals. Julian D. Gillmore has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Intellia. Julian D. Gillmore has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AstraZenica. Julian D. Gillmore has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for BridgeBio. Julian D. Gillmore has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer.
Laura Piera Obici Laura Piera Obici has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alnylam. Laura Piera Obici has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Akcea. Laura Piera Obici has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Pfizer.
Mark Taylor Mark Taylor has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Pfizer INC.
Brandon Edwards Brandon Edwards has nothing to disclose.
Holly Martin Holly Martin has nothing to disclose.
Garrett Malloy Timmons, MD Dr. Timmons has nothing to disclose.
Visesha Kakarla Miss Kakarla has nothing to disclose.
Andrew Valenciano, MD Dr. Valenciano has nothing to disclose.
Prajakta Badri, PhD Dr. Badri has received stock or an ownership interest from Alnylam Pharmaceuticals.
Soon-Chai Low, MD Dr. Low has nothing to disclose.
Hai Jiang, PhD Dr. Jiang has received personal compensation for serving as an employee of Amicus. Dr. Jiang has received stock or an ownership interest from Amicus.
Judy Toews Ms. Toews has nothing to disclose.
Nana Collett, Other Ms. Collett has received personal compensation for serving as an employee of NervGen. Ms. Collett has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Chinook Therapeutics. Ms. Collett has received stock or an ownership interest from Bioform.
Matvey Lukashev, PhD Dr. Lukashev has received personal compensation for serving as an employee of ALS Therapy Development Institute. Dr. Lukashev has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Nervgen. Dr. Lukashev has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eledon.
Marc DePaul, PhD, FRACP Dr. DePaul has received personal compensation for serving as an employee of NervGen Pharma. Dr. DePaul has received stock or an ownership interest from NervGen Pharma.
Ken Saida, MD,PhD Dr. Saida has nothing to disclose.
Mitchell Goldman, MD,PhD Dr. Goldman has received personal compensation for serving as an employee of Amicus. Dr. Goldman has received stock or an ownership interest from Amicus.
Jacqueline Shanley, CRC Miss Shanley has nothing to disclose.
Betty Lawrence, Other Ms. Lawrence has nothing to disclose.
Fazal Yakub Fazal Yakub has nothing to disclose.
Jeff Castelli, PhD Dr. Castelli has received personal compensation for serving as an employee of Amicus Therpeutics.
Annalise E. Miner, Other Ms. Miner has nothing to disclose.
Tasuku Ishihara, MD Dr. Ishihara has nothing to disclose.
Tiffany Tse Miss Tse has nothing to disclose.
Heidi Watson, RN Ms. Watson has nothing to disclose.
Nicole Julia Naimer, Other Ms. Naimer has nothing to disclose.
Terry Boodhoo, Other Mr. Boodhoo has received personal compensation for serving as an employee of AbbVie.
Swati Gupta, PhD Dr. Gupta has received personal compensation for serving as an employee of AbbVie.
Jie Shen Dr. Shen has received personal compensation for serving as an employee of AbbVie.
John Soliman Mr. Soliman has received personal compensation for serving as an employee of AbbVie.
Mayssa Attar, PhD Dr. Attar has received personal compensation for serving as an employee of AbbVie.
Jean Carruthers, MD Dr. Carruthers has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alastin. Dr. Carruthers has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Allergan Aesthetics ,an Abbve Corporation. Dr. Carruthers has received personal compensation in the range of $0-$499 for serving as a Consultant for Alphaeon (now Aeon BioPharma). Dr. Carruthers has received personal compensation in the range of $0-$499 for serving as a Consultant for Bonti (now with Allergan) . Dr. Carruthers has received personal compensation in the range of $0-$499 for serving as a Consultant for Fount Bio. Dr. Carruthers has received personal compensation in the range of $0-$499 for serving as a Consultant for InMode Aesthetics. Dr. Carruthers has received personal compensation in the range of $0-$499 for serving as a Consultant for Merz Aesthetic Global KOL Network. Dr. Carruthers has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Revance. Dr. Carruthers has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. The institution of Dr. Carruthers has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for “Up to Date” Neuromodulators and Fillers. Dr. Carruthers has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Dermatologic Surgery, Reviewer Plastic and Reconstructive Surgery and The Aesthetic Surgery Journal. Dr. Carruthers has received research support from Alastin. Dr. Carruthers has received research support from Allergan Aesthetics ,an Abbve Corporation. Dr. Carruthers has received research support from Alphaeon (now Aeon BioPharma). Dr. Carruthers has received research support from Bonti (now with Allergan) . Dr. Carruthers has received research support from Fount Bio. Dr. Carruthers has received research support from InMode Aesthetics. Dr. Carruthers has received research support from Merz Aesthetic Global KOL Network. Dr. Carruthers has received research support from Revance.
Sheela Sitaraman No disclosure on file